## Clinical Presentation and Risk Stratification This patient presents with **high-risk (massive) pulmonary embolism (PE)**: - **Risk factor:** Recent immobilization (hip fracture, 3 weeks) - **Symptoms:** Acute dyspnea, pleuritic chest pain, tachycardia (HR 118/min) - **Hemodynamics:** Hypotension (BP 95/60 mmHg) — **hemodynamic instability/shock** - **Oxygenation:** Severe hypoxemia (SpO₂ 88%) - **Imaging:** Wedge-shaped opacity (Hampton's hump — classic for PE) - **D-dimer:** Markedly elevated (2.8 μg/mL) ## Why Unfractionated Heparin (UFH) Is the Correct Answer **Key Point:** In a hemodynamically unstable patient with **very high clinical suspicion for PE**, current guidelines (ESC 2019, ACCP 2021) recommend **immediate anticoagulation with unfractionated heparin** without waiting for imaging confirmation, provided there is no absolute contraindication to anticoagulation. **High-Yield:** This patient has: - Wells score criteria strongly positive (immobilization, tachycardia, clinical suspicion of PE > alternative diagnosis) - Hemodynamic compromise (SBP <100 mmHg) - Markedly elevated D-dimer - Classic CXR finding (Hampton's hump) In this context, the **pretest probability is so high** that delaying anticoagulation to obtain CTPA is inappropriate and potentially harmful. UFH is preferred over LMWH in unstable PE because it can be rapidly reversed if thrombolysis becomes necessary. **Clinical Pearl (ESC 2019 Guidelines):** "In patients with high clinical probability of PE and hemodynamic instability, anticoagulation with UFH should be initiated immediately, even before diagnostic confirmation." CTPA is then obtained urgently to confirm diagnosis and guide escalation (thrombolysis for confirmed massive PE). Empirical thrombolysis (Option B) without imaging confirmation is reserved for **cardiac arrest** or **imminent cardiovascular collapse** where imaging is impossible — this patient, while hypotensive, is not in cardiac arrest. ## Why CTPA Alone Is Incorrect as the "Next Step" CTPA is the gold standard for PE diagnosis, but it should **not precede anticoagulation** in a hemodynamically unstable patient with very high clinical suspicion. Anticoagulation must be started immediately; CTPA follows concurrently or shortly after to confirm diagnosis and guide thrombolysis decisions. ## Why Empirical Thrombolysis Is Premature Thrombolysis carries a 1–3% risk of intracranial hemorrhage and significant systemic bleeding. It is indicated for **confirmed massive PE** or cardiac arrest. This patient is hypotensive but not in cardiac arrest; imaging confirmation should be obtained after initiating heparin before committing to thrombolysis. ## Why Echocardiography Before Anticoagulation Is Incorrect Bedside echo may demonstrate RV dysfunction (supporting PE diagnosis) but **should not delay anticoagulation**. It is a complementary tool, not a prerequisite for starting treatment. ## Management Algorithm ``` Suspected High-Risk PE (Hemodynamic Instability) ↓ Immediate UFH anticoagulation (no absolute contraindication) ↓ Urgent CTPA to confirm diagnosis ↓ PE confirmed + massive → Thrombolysis + continue anticoagulation PE confirmed + submassive → Anticoagulation ± catheter-directed therapy ``` [cite: ESC Guidelines on Acute PE 2019; Harrison's Principles of Internal Medicine, 21e, Ch. 294; ACCP Antithrombotic Therapy for VTE Disease 2021]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.